The role of active inducible nitric oxide synthase expression in the pathogenesis of capillary leak syndrome resulting from interleukin-2 therapy in mice

Laboratory Investigation

Volumn 76, Issue 1, 1997, Pages 53-65

  Orucevic, Amila ^a   Hearn, Stephen ^a   Lala, Peeyush K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY LEAK SYNDROME; CAPILLARY RESISTANCE; CONTROLLED STUDY; ENZYME INDUCTION; HISTOPATHOLOGY; IMMUNOMODULATION; LUNG EDEMA; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

ANIMALS; ARTERIOLES; CAPILLARY LEAK SYNDROME; CONNECTIVE TISSUE; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; ENZYME INHIBITORS; FEMALE; HUMANS; INTERLEUKIN-2; LUNG; MACROPHAGES; MICE; MICE, INBRED C3H; MICROSCOPY, ELECTRON; MUSCLE FIBERS; MUSCLE, SKELETAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RECOMBINANT PROTEINS; SPLEEN;

EID: 0031017497     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Assreuy J, Cunha FQ, Liew FY, and Moncada S (1993). Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 108:833-837.
2. Davison W and Woof C (1978). Comparison of different forms of cadmium as reducing agents for the batch determination of nitrate. Analyst 103:403-406.
3. Dubinett SM, Huang M, Lichtenstein A, McBride WH, Wang J, Markovitz G, Kelley D, Grody WW, Mintz LE, and Dhanani S (1994). Tumor necrosis factor-α plays a central role in interleukin-2 induced pulmonary vascular leak and lymphocyte accumulation. Cell Immunol 157:170-180.
4. Dutcher JP, Creekmore S, Weiss GR, Margolin K, Markowitz AB, Roper M, Parkinson D, Ciobanu N, Fisher RI, Boldt DH, Doroshow JH, Rayner AA, Hawkins M, and Atkins M (1989). A phase II study of interleukin-2 and lymphokine activated killer (LAK) cells in patients with metastatic malignant melanoma. J Clin Oncol 7:477-485.
5. Estrada C, Gomez C, Martin C, Moncada S, and Gonzalez C (1992). Nitric oxide mediates tumor necrosis factor-α cytotoxicity in endothelial cells. Biochem Biophys Res Commun 186:475-482.
6. Fisher RI, Coltman CA, Doroshow JA, Rayner AA, Hawkins MJ, Mier JW, Wiernik P, McMannis JD, Weiss GR, Margolin KA, Gemlo BT, Hoth DF, Parkinson DR, and Paietta E (1988). A phase II study of interleukin-2 and lymphokine activated killer cells (LAK) in metastatic renal cancer. Ann Intern Med 108:518-523.
7. G-monomethyl-[scapl-arginine, an inhibitor of nitric oxide production (abstract). Proc Am Assoc Cancer Res 35:251.
8. Goldblum SE, Yoneda K, Cibull M, Pearson T, Hall C, and Marshall ME (1990). Human recombinant interleukin-2 provokes acute pulmonary vascular endothelial injury in rabbits. J Biol Response Mod 9:127-139.
9. 15N]nitrate in biological fluids. Anal Biochem 126:131-138.
10. Hibbs JB Jr, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMurry MP, Kushner JP, and Samlowski WE (1992). Evidence for cytokine-inducible nitric oxide synthesis from I-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89:867-877.
11. Hierck BP, Iperen LV, Gittenberger-De Groot AC, and Poelmann RE (1994). Modified indirect immunodetection allows study of murine tissue with mouse monoclonal antibodies. J Histochem Cytochem 42:1499-1502.
12. Hunter EE (1993). Practical electron microscopy. New York: Cambridge University Press.
13. Kelm M, Feelisch M, Grube R, Motz W, and Stauer BE (1992). Metabolism of endothelium-derived nitric oxide in human blood. In: Moncada S, Marietta MA, Hibbs JB Jr, and Higgs EA, editors. The biology of nitric oxide. London: Portland Press, 319-322.
14. G-Monomethyl-L-arginine, an inhibitor of nitric oxide production, reverses interleukin-2 mediated hypotension. Crit Care Med 23:1018-1024.
15. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172:1132-1138.
16. Knowles RG and Moncada S (1994). Nitric oxide synthases in mammals. Biochem J 298:249-258.
17. Luss H, DiSilvio M, Litton AL, y Vedia LM, Nussler AK, and Billiar TR (1994). Inhibition of nitric oxide synthesis enhances the expression of inducible nitric oxide synthase mRNA and protein in a model of chronic liver inflammation. Biochem Biophys Res Commun 204:635-640.
18. Mertens WC, Bramwell VHC, Banerjee D, Gwadry-Sridhar F, Al-Mutter N, Parhar RS, and Lala PK (1993a). Sustained oral indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced renal cell carcinoma. Cancer Biotherapy 8:229-233.
19. Mertens WC, Bramwell VHC, Banerjee D, Gwadry-Sridhar F, and Lala PK (1993b). Sustained indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced malignant melanoma: A phase II study. Clin Oncol 5:107-113.
20. Miles D, Thomsen L, Balkwill F, Thavasu P, and Moncada S (1994). Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin-2. Eur J Clin Invest 24:287-290.
21. Moncada S and Higgs A (1993). The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012.
22. Morris SM and Billiar TR (1994). New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266:E829-E839.
23. Ochoa JB, Curti B, Peitzman AB, Simmons RL, Billiar TR, Hoffman R, Rault R, Longo DL, Urba WJ, and Ochoa AC (1992). Increased circulating nitrogen oxides after human tumor immunotherapy: Correlation with toxic hemodynamic changes. J Natl Cancer Inst 84:864-867.
24. Oppenheim MH and Lotze MT (1994). Interleukin-2: Solid-tumor therapy. Oncology 51:154-169.
25. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on IL-2-induced capillary leakage and anti-tumor responses in healthy and tumor bearing mice. Cancer Immunol Immunother 42:38-46.
26. G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor bearing mice. Cell Immunol 169:125-132.
27. G-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin-2 induced capillary leakage and reduces tumor growth in adenocarcinoma bearing mice. Br J Cancer 72: 189-197.
28. G-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin-2 induced capillary leak syndrome in healthy mice. J Immunother 18:210-220.
29. Palmer RMJ, Bridge L, Foxwell NA, and Moncada S (1992). The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol 105:11-12.
30. Palmer RMJ, Ferrige AS, and Moncada S (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526.
31. Parhar RS and Lala PK (1987). Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2. J Exp Med 165:14-28.
32. Petros A, Bennett D, and Vallance P (1991). Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557-1558.
33. Pinchon MC, Bernaudin JF, and Bignon J (1980). Pleural permeability in the rat. I. Ultrastructural basis. Biol Cell 37:269-272.
34. Renzi PM, Du T, Sapienza S, Wang NS, and Martin JG (1991). Acute effects of interleukin-2 lung mechanics and airway responsiveness in rats. Am Rev Respir Dis 143:380-385.
35. Rosenberg SA (1989). Clinical immunotherapy studies in the surgery branch of the U. S. National Cancer Institute. Cancer Treat Rev 16(Suppl A):115-121.
36. 2+-independent nitric oxide synthases. Febs Lett 291:145-149.
37. Siegel JP and Puri RK (1991). Interleukin-2 toxicity. J Clin Oncol 9:694-704.
38. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, and Moncada S (1995). Nitric oxide synthase activity in human breast cancer. Br J Cancer 72:41-44.
39. Wright CE, Rees DD, and Moncada S (1992). Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26:48-57.
40. Xue C, Botkin SJ, and Johns RA (1996). Localization of endothelial NOS at the basal microtubule membrane in ciliated epithelium of rat lung. J Histochem Cytochem 44: 463-471.
41. Zar JH (1974). Biostatistical analysis. Englewood Cliffs, NJ: Prentice-Hall.